Evolysse ® Sculpt — Regulatory decision
2026
We anticipate two additional Evolysse ® products, Evolysse ® Sculpt and Evolysse ® Lips, to be approved in the United States in 2026 and 2027, respectively.Source filing
EOLS biotech catalysts & pipeline
EVOLUS INC · Data as of 2026-09-08
Upcoming catalysts
Evolysse Sculpt — Regulatory decision
Q4 2026
◦ The anticipated U.S. approval of Evolysse ® Sculpt in the fourth quarter of 2026; however, guidance assumes no revenue contribution from the product.Source filing
Evolysse ® Lips — Regulatory decision
2027
We anticipate two additional Evolysse ® products, Evolysse ® Sculpt and Evolysse ® Lips, to be approved in the United States in 2026 and 2027, respectively.Source filing
Estyme — Regulatory decision
2028
Commercialization of Estyme ® in Canada, Australia, and New Zealand is expected in 2028, subject to applicable regulatory approvals and review processes.Source filing